-+ 0.00%
-+ 0.00%
-+ 0.00%

Voyager Therapeutics Q4 EPS $(0.46) Beats $(0.54) Estimate, Sales $15.336M Beat $10.491M Estimate

Benzinga·03/09/2026 20:03:15
Listen to the news
Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.54) by 14.66 percent. This is a 22.03 percent increase over losses of $(0.59) per share from the same period last year. The company reported quarterly sales of $15.336 million which beat the analyst consensus estimate of $10.491 million by 46.18 percent. This is a 144.28 percent increase over sales of $6.278 million the same period last year.